Last reviewed · How we verify

Oxygen 21 % — Competitive Intelligence Brief

Oxygen 21 % (Oxygen 21 %) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Respiratory/Critical Care or Wound Healing.

phase 3 Respiratory/Critical Care or Wound Healing Small molecule Live · refreshed every 30 min

Target snapshot

Oxygen 21 % (Oxygen 21 %) — University of South Florida. Oxygen 21% is a hyperoxic gas mixture that increases arterial oxygen partial pressure to enhance tissue oxygenation and potentially promote healing or therapeutic benefit in hypoxic conditions.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Oxygen 21 % TARGET Oxygen 21 % University of South Florida phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Oxygen 21 % — Competitive Intelligence Brief. https://druglandscape.com/ci/oxygen-21. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: